Lemonade (LMND) Confirms 4.5M Share Proposed Public Offering of Common Stock

Lemonade, Inc. (“Lemonade”) (NYSE: LMND), the insurance company powered by artificial intelligence and behavioral economics, today announced that it intends to offer 3,000,000 shares of its common stock for sale in an underwritten public offering (the “Primary Offering”). Certain selling stockholders of Lemonade also intend to offer 1,524,314 shares of Lemonade’s common stock for sale in the offering (the “Secondary Offering” and together with the Primary Offering, the “Offering”). Lemonade also intends to grant the underwriters 30-day options to purchase up to an additional 678,647 shares of Lemonade’s common stock.

Lemonade intends to use its net proceeds from the Primary Offering for general corporate purposes. Lemonade will not receive any proceeds from the sale of shares by the selling stockholders in the Secondary Offering.

Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, Allen & Company LLC and Barclays Capital Inc. are serving as joint active bookrunners.

A registration statement relating to the Offering has been filed with the Securities and Exchange Commission (the “SEC”) but has not yet become effective (the “Registration Statement”). The Offering will be made only by means of a prospectus.

You May Also Be Interested In

• Rapid Line sees stock surge with no known corporate cause
• Singularity Future Technology closes $1.8M registered direct offering
• FDA grants accelerated approval to Ultragenyx gene therapy for GSDIa